Prevalence and clinical association of MET gene overexpression and amplification in patients with NSCLC: Results from the European Thoracic Oncology Platform (ETOP) Lungscape project.
dc.contributor.author | Bubendorf, L | |
dc.contributor.author | Dafni, U | |
dc.contributor.author | Schöbel, M | |
dc.contributor.author | Finn, S | |
dc.contributor.author | Tischler, V | |
dc.contributor.author | Sejda, A | |
dc.contributor.author | Marchetti, A | |
dc.contributor.author | Thunnissen, E | |
dc.contributor.author | Verbeken, E | |
dc.contributor.author | Warth, A | |
dc.contributor.author | Sansano, I | |
dc.contributor.author | Cheney, R | |
dc.contributor.author | Speel, E | |
dc.contributor.author | Nonaka, Daisuke | |
dc.contributor.author | Monkhorst, K | |
dc.contributor.author | Hager, H | |
dc.contributor.author | Martorell, M | |
dc.contributor.author | Savic, S | |
dc.contributor.author | Kerr, K | |
dc.contributor.author | Tan, Q | |
dc.contributor.author | Tsourti, Z | |
dc.contributor.author | Geiger, T | |
dc.contributor.author | Kammler, R | |
dc.contributor.author | Schulze, K | |
dc.contributor.author | Das-Gupta, A | |
dc.contributor.author | Shames, D | |
dc.contributor.author | Peters, S | |
dc.contributor.author | Stahel, R | |
dc.date.accessioned | 2017-09-22T15:36:47Z | |
dc.date.available | 2017-09-22T15:36:47Z | |
dc.date.issued | 2017-09 | |
dc.identifier.citation | Prevalence and clinical association of MET gene overexpression and amplification in patients with NSCLC: Results from the European Thoracic Oncology Platform (ETOP) Lungscape project. 2017, 111:143-149 Lung Cancer | en |
dc.identifier.issn | 1872-8332 | |
dc.identifier.pmid | 28838386 | |
dc.identifier.doi | 10.1016/j.lungcan.2017.07.021 | |
dc.identifier.uri | http://hdl.handle.net/10541/620566 | |
dc.description.abstract | In a well-defined NSCLC cohort of the ETOP Lungscape program, we explored the epidemiology of IHC MET overexpression and amplification, their inter-correlation, and their association to outcome. | |
dc.language.iso | en | en |
dc.rights | Archived with thanks to Lung cancer (Amsterdam, Netherlands) | en |
dc.title | Prevalence and clinical association of MET gene overexpression and amplification in patients with NSCLC: Results from the European Thoracic Oncology Platform (ETOP) Lungscape project. | en |
dc.type | Article | en |
dc.contributor.department | Institute of Pathology, University Hospital Basel, Basel, Switzerland | en |
dc.identifier.journal | Lung Cancer | en |
html.description.abstract | In a well-defined NSCLC cohort of the ETOP Lungscape program, we explored the epidemiology of IHC MET overexpression and amplification, their inter-correlation, and their association to outcome. |